Historical returns of Y-mAbs Therapeutics (id:8187 YMAB)
Annual returns
| 2019 | 2020 | 2021 | 2022 | 2023 | YTD | |
|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics Inc | 56.56 % | 56.23 % | -67.12 % | -69.88 % | 38.06 % | 54.45 % |
| United States | 55.88 % (2856, Country_ID:6) | 120.80 % (2997, Country_ID:6) | 93.58 % (3236, Country_ID:6) | 1,141.30 % (3606, Country_ID:6) | 186.74 % (3640, Country_ID:6) | 28.17 % (3658, Country_ID:6) |
Trailing returns
| 1D | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics Inc | 3.17 % | -7.38 % | -29.71 % | -14.95 % | 54.45 % | 92.78 % | -16.82 % | -18.61 % | 0.000 % | 0.000 % |
| All United States stocks | 2.03 % | 3.67 % | 7.67 % | 14.27 % | 27.02 % | 46.40 % | -3.31 % | 5.71 % | 3.31 % | 6.92 % |
Monthly returns
| January | February | March | April | May | June | July | August | September | October | November | December | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 |
89.76 %
|
30.27 %
|
-20.41 %
|
-7.03 %
|
-21.22 %
|
-0.33 %
|
2.25 %
|
16.63 %
|
-6.61 %
|
10.59 %
|
|
|
54.45 % |
2023 |
-9.11 %
|
-16.48 %
|
31.15 %
|
21.50 %
|
35.73 %
|
-15.97 %
|
-9.78 %
|
-15.78 %
|
7.28 %
|
-0.74 %
|
16.29 %
|
9.47 %
|
38.06 % |
2022 |
-38.95 %
|
-10.07 %
|
31.71 %
|
-30.58 %
|
47.92 %
|
21.62 %
|
3.38 %
|
4.08 %
|
-8.91 %
|
-75.36 %
|
20.81 %
|
8.44 %
|
-69.88 % |
2021 |
-14.79 %
|
-17.69 %
|
-22.00 %
|
-1.64 %
|
18.92 %
|
-6.01 %
|
-2.30 %
|
-7.62 %
|
-6.82 %
|
-13.46 %
|
-30.17 %
|
-7.27 %
|
-67.12 % |
2020 |
4.10 %
|
-11.52 %
|
-12.27 %
|
35.24 %
|
15.45 %
|
13.36 %
|
-19.02 %
|
21.25 %
|
-11.73 %
|
10.64 %
|
17.48 %
|
-0.98 %
|
56.23 % |
2019 |
3.11 %
|
4.94 %
|
20.23 %
|
-13.69 %
|
-11.82 %
|
11.56 %
|
-3.03 %
|
18.56 %
|
-0.46 %
|
17.59 %
|
13.98 %
|
-8.36 %
|
56.56 % |
Avg |
5.69 %
|
-3.43 %
|
4.73 %
|
0.64 %
|
14.16 %
|
4.04 %
|
-4.75 %
|
6.18 %
|
-4.54 %
|
-8.46 %
|
7.68 %
|
0.26 %
|
51.33 % |